NCT04117958 Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers Status TERMINATED Phase PHASE1
NCT04113018 Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04098250 Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH Status COMPLETED Phase PHASE2
NCT04087720 Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant Status COMPLETED Phase PHASE4
NCT04068181 Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07). Status COMPLETED Phase PHASE2
NCT04058028 Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT04057937 A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis Status COMPLETED Phase PHASE2
NCT04048343 Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma Status COMPLETED Phase PHASE3
NCT04046549 A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant Status COMPLETED Phase PHASE2
NCT04044560 Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant Status TERMINATED Phase PHASE2
NCT04040894 Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease Status APPROVED_FOR_MARKETING Phase N/A
NCT04034173 Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation Status NOT_YET_RECRUITING Phase PHASE2
NCT04031027 A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice Status COMPLETED Phase N/A
NCT03994731 Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout Status COMPLETED Phase PHASE4
NCT03989544 A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult Subjects Status COMPLETED Phase PHASE1